Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates. (2015)
Attributed to:
Pre-clinical development of a simian adenovirus vectored respiratory syncytial virus (RSV) vaccine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/mtm.2015.18
PubMed Identifier: 26015988
Publication URI: http://europepmc.org/abstract/MED/26015988
Type: Journal Article/Review
Volume: 2
Parent Publication: Molecular therapy. Methods & clinical development
ISSN: 2329-0501